Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 5
1982 6
1983 7
1984 5
1985 4
1986 3
1987 6
1988 10
1989 10
1990 17
1991 24
1992 23
1993 32
1994 36
1995 36
1996 41
1997 41
1998 69
1999 71
2000 75
2001 68
2002 76
2003 67
2004 69
2005 75
2006 72
2007 58
2008 66
2009 58
2010 63
2011 57
2012 60
2013 42
2014 74
2015 63
2016 56
2017 53
2018 61
2019 41
2020 58
2021 55
2022 40
2023 44
2024 45
2025 53
2026 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,838 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma.
O'Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Ivanov S, Reddel HK. O'Byrne PM, et al. N Engl J Med. 2018 May 17;378(20):1865-1876. doi: 10.1056/NEJMoa1715274. N Engl J Med. 2018. PMID: 29768149 Free article. Clinical Trial.
Patients were randomly assigned to one of three regimens: twice-daily placebo plus terbutaline (0.5 mg) used as needed (terbutaline group), twice-daily placebo plus budesonide-formoterol (200 mug of budesonide and 6 mug of formoterol) used as needed (budesonide …
Patients were randomly assigned to one of three regimens: twice-daily placebo plus terbutaline (0.5 mg) used as needed (terbutaline group), …
As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma.
Bateman ED, Reddel HK, O'Byrne PM, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Siwek-Posluszna A, FitzGerald JM. Bateman ED, et al. N Engl J Med. 2018 May 17;378(20):1877-1887. doi: 10.1056/NEJMoa1715275. N Engl J Med. 2018. PMID: 29768147 Free article. Clinical Trial.
Patients were randomly assigned to receive twice-daily placebo plus budesonide-formoterol (200 mug of budesonide and 6 mug of formoterol) used as needed or budesonide maintenance therapy with twice-daily budesonide (200 mug) plus terbutaline (0.5 mg) u …
Patients were randomly assigned to receive twice-daily placebo plus budesonide-formoterol (200 mug of budesonide and 6 mug of …
Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma.
Beasley R, Holliday M, Reddel HK, Braithwaite I, Ebmeier S, Hancox RJ, Harrison T, Houghton C, Oldfield K, Papi A, Pavord ID, Williams M, Weatherall M; Novel START Study Team. Beasley R, et al. N Engl J Med. 2019 May 23;380(21):2020-2030. doi: 10.1056/NEJMoa1901963. Epub 2019 May 19. N Engl J Med. 2019. PMID: 31112386 Clinical Trial.
Patients were randomly assigned to one of three treatment groups: albuterol (100 mug, two inhalations from a pressurized metered-dose inhaler as needed for asthma symptoms) (albuterol group); budesonide (200 mug, one inhalation through a Turbuhaler twice daily) plus as-nee …
Patients were randomly assigned to one of three treatment groups: albuterol (100 mug, two inhalations from a pressurized metered-dose inhale …
Albuterol-Budesonide Pressurized Metered Dose Inhaler in Patients With Mild-to-Moderate Asthma: Results of the DENALI Double-Blind Randomized Controlled Trial.
Chipps BE, Israel E, Beasley R, Panettieri RA Jr, Albers FC, Rees R, Dunsire L, Danilewicz A, Johnsson E, Cappelletti C, Papi A. Chipps BE, et al. Chest. 2023 Sep;164(3):585-595. doi: 10.1016/j.chest.2023.03.035. Epub 2023 Mar 30. Chest. 2023. PMID: 37003355 Free PMC article. Clinical Trial.
RESEARCH QUESTION: Do both albuterol and budesonide contribute to the efficacy of the albuterol-budesonide combination pressurized metered-dose inhaler in patients with asthma? ...Change from baseline in FEV(1) AUC(0-6h) over 12 weeks was greater with albuterol-b …
RESEARCH QUESTION: Do both albuterol and budesonide contribute to the efficacy of the albuterol-budesonide combination pressur …
Budesonide for induction of remission in Crohn's disease.
Rezaie A, Kuenzig ME, Benchimol EI, Griffiths AM, Otley AR, Steinhart AH, Kaplan GG, Seow CH. Rezaie A, et al. Cochrane Database Syst Rev. 2015 Jun 3;2015(6):CD000296. doi: 10.1002/14651858.CD000296.pub4. Cochrane Database Syst Rev. 2015. PMID: 26039678 Free PMC article.
MAIN RESULTS: Fourteen studies (1805 patients) were included: Nine (779 patients) compared budesonide to conventional corticosteroids, three (535 patients) were placebo-controlled, and two (491 patients) compared budesonide to mesalamine. ...Studies comparing bud …
MAIN RESULTS: Fourteen studies (1805 patients) were included: Nine (779 patients) compared budesonide to conventional corticosteroids …
Budesonide-formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
Hatter L, Holliday M, Oldfield K, Kearns C, Barry T, Black M, Bruce P, Colman A, Dickinson E, Eathorne A, Harwood M, Hills T, Lamb R, Kerse K, Krishnamoorthy S, Martindale J, Semprini A, Shortt N, McNamara D, Byrnes CA, Dalziel SR, Bush A, Weatherall M, Beasley R; CARE study team. Hatter L, et al. Lancet. 2025 Oct 4;406(10511):1473-1483. doi: 10.1016/S0140-6736(25)00861-X. Epub 2025 Sep 28. Lancet. 2025. PMID: 41033330 Clinical Trial.
Participants were randomly assigned (1:1) to either budesonide 50 mug-formoterol 3 mug, two actuations as needed, or salbutamol 100 mug, two actuations as needed. ...We randomly assigned 360 (94%) participants to treatment (179 [50%] to the budesonide-formoterol gro …
Participants were randomly assigned (1:1) to either budesonide 50 mug-formoterol 3 mug, two actuations as needed, or salbutamol 100 m …
Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
Hardy J, Baggott C, Fingleton J, Reddel HK, Hancox RJ, Harwood M, Corin A, Sparks J, Hall D, Sabbagh D, Mane S, Vohlidkova A, Martindale J, Williams M, Shirtcliffe P, Holliday M, Weatherall M, Beasley R; PRACTICAL study team. Hardy J, et al. Lancet. 2019 Sep 14;394(10202):919-928. doi: 10.1016/S0140-6736(19)31948-8. Epub 2019 Aug 23. Lancet. 2019. PMID: 31451207 Clinical Trial.
We investigated the efficacy of combination budesonide-formoterol reliever therapy compared with maintenance budesonide plus as-needed terbutaline. ...Nasopharyngitis was the most common adverse event in both groups, occurring in 154 (35%) of 440 patients receiving …
We investigated the efficacy of combination budesonide-formoterol reliever therapy compared with maintenance budesonide plus a …
Budesonide treatment for microscopic colitis: systematic review and meta-analysis.
Sebastian S, Wilhelm A, Jessica L, Myers S, Veysey M. Sebastian S, et al. Eur J Gastroenterol Hepatol. 2019 Aug;31(8):919-927. doi: 10.1097/MEG.0000000000001456. Eur J Gastroenterol Hepatol. 2019. PMID: 31211724
To conduct a systematic review and meta-analysis on the efficacy and safety of budesonide in the treatment of MC. We searched Medline, Embase and Central databases using predefined search methodology for randomised trials using budesonide in the treatment of MC. ... …
To conduct a systematic review and meta-analysis on the efficacy and safety of budesonide in the treatment of MC. We searched Medline …
Budesonide Versus Mesalamine in Microscopic Colitis: A Comparative Meta-analysis of Randomized Controlled Trials.
Malik A, Goyal H, Adler DG, Javaid S, Malik MI, Singh S, Nadir A, Abegunde AT. Malik A, et al. J Clin Gastroenterol. 2025 Aug 1;59(7):629-639. doi: 10.1097/MCG.0000000000002025. J Clin Gastroenterol. 2025. PMID: 39042479
OBJECTIVE: We aim to assess the efficacy and safety of budesonide compared with mesalamine for induction of remission in MC patients. METHODS: We searched the Cochrane Library, Scopus, Web of Science, and PubMed for relevant clinical trials comparing either mesalamine or …
OBJECTIVE: We aim to assess the efficacy and safety of budesonide compared with mesalamine for induction of remission in MC patients. …
Effects of omalizumab combined with budesonide formoterol on clinical efficacy, pulmonary function, immune function, and adverse reactions in children with moderate and severe allergic asthma.
Chen F, Liang L, Chu FF, Lu C, Xu C. Chen F, et al. Allergol Immunopathol (Madr). 2023 Jul 1;51(4):182-188. doi: 10.15586/aei.v51i4.926. eCollection 2023. Allergol Immunopathol (Madr). 2023. PMID: 37422796 Clinical Trial.
OBJECTIVE: To evaluate the clinical efficacy and safety of combining omalizumab with budesonide formoterol to treat children with moderate and severe allergic asthma, and investigate the effect of this combination therapy on pulmonary and immune functions. ...The patients …
OBJECTIVE: To evaluate the clinical efficacy and safety of combining omalizumab with budesonide formoterol to treat children with mod …
1,838 results